References
- Marquet P. Pharmacology of high‐dose buprenorphine. Buprenorphine Therapy of Opiate Addiction1st ed, P Kintz, P Marquet. Humana Press, Totowa 2002; 1–9
- Gaulier J M, Marquet P, Lacassie E, Dupuy J L, Lachâtre G. Fatal intoxication following buprenorphine massive dose. J Forensic Sci 2000; 45(1)226–228
- Kintz P. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci Int 2001; 121(1–2)65–69
- Boyd J, Randell T, Luurila H, Kuisma M. Serious overdoses involving buprenorphine in Helsinki. Acta Anaesthesiol Scand 2003; 47(8)1031–1033
- Hoja H, Marquet P, Verneuil B, Lotfi H, Dupuy J L, Lachatre G. Determination of buprenorphine and norbuprenorphine in whole blood by liquid chromatography‐mass spectrometry. J Anal Toxicol 1997; 21(2)160–165
- Spadari M, Arditti J, Affaton M F, David J M, Valli M. Accidental narcotic and buprenorphine poisoning in children notified at the Marseille Poison Center between 1993 and 1999. Therapie 2000; 55(6)705–708
- Bickel W K, Stitzer M L, Bigelow G E, Liebson I A, Jasinski D R, Johnson R E. Buprenorphine: dose‐related blockade of opioid challenge effects in opioid dependent humans. J Pharmacol Exp Ther 1988; 247(1)47–53
- Teoh S K, Mello N K, Mendelson J H, Kuehnle J, Gastfriend D R, Rhoades E, Sholar W. Buprenorphine effects on morphine‐ and cocaine‐induced subjective responses by drug‐dependent men. J Clin Psychopharmacol 1994; 14(1)15–27
- Bridge P T, Fudala P J, Herbert S. Office‐based treatment of opiate addiction with a sublingual tablet formulation of buprenorphine and naxalone. N Engl J Med 2003; 349(10)949–958
- Schuh K J, Johanson C E. Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet. Drug Alcohol Depend 1999; 56(1)55–60